Ralf M. Nass MD
Diabetes, Lipid Metabolism
Assistant Professor, Internal Medicine, University of Virginia School of Medicine
Join to View Full Profile
415 Ray C. Hunt DriveCharlottesville, VA 22903
Phone+1 434-924-1825
Fax+1 434-924-9616
Dr. Nass is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of Virginia Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2011 - 2013
University of Virginia School of MedicineClass of 1988
Certifications & Licensure
VA State Medical License 2006 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Clinical Trials
- Study of Glucagon, Ghrelin and Growth Hormone as Counterregulatory Hormones Start of enrollment: 2012 Dec 01
- SGLT2 Inhibitor Adjunctive Therapy to Closed Loop Control in Type 1 Diabetes Mellitus Start of enrollment: 2020 Feb 24
Publications & Presentations
PubMed
- Adaptive Biobehavioral Control: A Pilot Analysis of Human-Machine Coadaptation in Type 1 Diabetes.Patricio Colmegna, Ryan McFadden, Chiara Fabris, Benjamin Lobo, Ralf Nass
Diabetes Technology & Therapeutics. 2024-09-01 - 4 citationsIntensive, telemedicine-based, self-management program for rural, underserved patients with diabetes mellitus: Re-entry of retired endocrinologists into practice.Richard J Santen, Ralf Nass, Cindy Cunningham, Carla Horton, Wei Yue
Journal of Telemedicine and Telecare. 2023-02-01 - 16 citationsAutomated Insulin Delivery with SGLT2i Combination Therapy in Type 1 Diabetes.Jose Garcia-Tirado, Leon Farhy, Ralf Nass, Laura Kollar, Mary Clancy-Oliveri
Diabetes Technology & Therapeutics. 2022-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
